Impact News +++ Quantum Announces Preliminary Fiscal Third Quarter 2026 Financial Results (Business Wire) +++ QUANTUM CORP Aktie +7,85%

BOSTON SCIENTIFIC Aktie

>Aktienkurs

77.8 EUR -3.5% (Tradegate)

Ask: 78.6 EUR / 130 Stück

Bid: 76.6 EUR / 50 Stück

Tagesumsatz: 1818 Stück

Realtime Kurs von 7:30 bis 22 Uhr!

Aktie über LYNX handeln

Intraday

1 Jahr

>Performance

1 Woche: -5,0%

1 Monat: +1,8%

3 Monate: -3,1%

6 Monate: -10,7%

1 Jahr: -13,8%

laufendes Jahr: -1,5%

>BOSTON SCIENTIFIC Aktie

Name:

BOSTON SCIENTIFIC DL-,01

Land:

USA

Sektor:

Gesundheit

ISIN/ Wkn:

US1011371077 / 884113

Symbol/ Ticker:

BSX (Frankfurt) / BSX (NYSE)

Kürzel:

FRA:BSX, ETR:BSX, BSX:GR, NYSE:BSX

Index:

S&P500

Webseite:

http://www.bostonscientif..

Profil:

Boston Scientific Corporation, a leading global me..
>Volltext..

Marktkapitalisierung:

121850.65 Mio. EUR

Unternehmenswert:

131161.93 Mio. EUR

Umsatz:

16616.07 Mio. EUR

EBITDA:

4120.96 Mio. EUR

Nettogewinn:

2397.52 Mio. EUR

Gewinn je Aktie:

1.62 EUR

Schulden:

10343.18 Mio. EUR

Liquide Mittel:

1179.01 Mio. EUR

Operativer Cashflow:

3972.4 Mio. EUR

Bargeldquote:

0.26

Umsatzwachstum:

15.4%

Gewinnwachstum:

47.92%

Dividende je Aktie:

Dividendenrendite:

Dividendenschätzung:

Insiderhandel:

Suchwörter:

BOSTON SCIENTIFIC

Letzte Datenerhebung:

15.01.26

>Kennzahlen

Aktien/ Unternehmen:

Aktien: 1482.44 Mio. St.

Frei handelbar: 99.61%

Leerverk. Aktien: 1.35%

Rückkaufquote: -0.2%

Mitarbeiter: 53000

Umsatz/Mitarb.: 0.27 Mio. EUR

Analysten:

Analystenrating: Strong buy

Kursziel: 34.4%

Bewertung:

KGV: 50.46

KGV lG: 31.1

KUV: 7.46

KBV: 5.98

PEG-Ratio: 0.95

EV/EBITDA: 31.83

Rentabilität:

Bruttomarge: 62.57%

Gewinnmarge: 14.43%

Operative Marge: 17.82%

Managementeffizenz:

Gesamtkaprendite: 6.91%

Eigenkaprendite: 12.66%

>Anleihen

Es sind 1 Anleihen zur BOSTON SCIENTIFIC Aktie bekannt.

>Peer Group

Es sind 592 Aktien bekannt.

>Chart & Kurs - NYSE

>Alle News

15.01.26 - 14:31	US-Vorbörse: Goldman Sachs, Boston Scientific, Morgan Stanley und TSMC mit viel Bewegung (Investing.com DE)
	Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

15.01.26 - 14:27	Penumbra surges on news of $14.5 billion Boston Scientific buyout, BSX down (Investing.com)
	Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...

15.01.26 - 14:18	Boston Scientific is buying Penumbra for $14.5 billion, gaining entry to ‘fast-growing’ vascular segments (MarketWatch)
	Penumbra's stock was up about 14% after the deal was announced Thursday morning....

15.01.26 - 14:12	Goldman Sachs and Boston Scientific fall premarket; Morgan Stanley, TSMC rise (Investing.com)
	Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...

15.01.26 - 13:54	Boston Scientific beefs up heart device portfolio with $14.5 billion Penumbra deal (CNBC)
	Boston Scientific said on Thursday it will buy ⁠medtech firm Penumbra in a deal valued at ‍about $14.5 billion ‍to ‍expand its portfolio of cardiovascular devices....

15.01.26 - 13:42	Boston Scientific to acquire Penumbra for enterprise value of ~$14.5B (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

15.01.26 - 13:30	Boston Scientific to Buy Penumbra for $15 Billion in Cash, Stock (WSJ EN)
	Boston Scientific has agreed to buy thrombectomy company Penumbra for about $15 billion in cash and stock in a deal that bolsters its cardiovascular portfolio....

15.01.26 - 13:24	Boston Scientific Buys Device Maker Penumbra for $14.5 Billion (Bloomberg)
	Boston Scientific Corp. agreed to buy medical device maker Penumbra Inc. in a deal with an enterprise value of $14.5 billion....

15.01.26 - 13:24	Boston Scientific to Buy Penumbra for $15 Billion in Cash, Stock (WSJ EN)
	Boston Scientific has agreed to buy thrombectomy company Penumbra for about $15 billion in cash and stock in a deal that bolsters its cardiovascular portfolio....

15.01.26 - 13:15	Boston Scientific to buy Penumbra in $14.5 billion deal (Reuters EN)
	Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...

15.01.26 - 13:03	Boston Scientific announces agreement to acquire Penumbra, Inc. (PR Newswire)
	Acquisition to expand Boston Scientific's cardiovascular portfolio and further address increasing prevalence of vascular diseases Provides scaled entry into mechanical thrombectomy and neurovascular, key strategic adjacencies Conference call at 8:00 a.m. ET to discuss details of the......

14.01.26 - 17:30	The Zacks Analyst Blog Highlights AngioDynamics, Boston Scientific and Medtronic (Zacks)
	AngioDynamics shows how product mix shifts toward higher-margin Med Tech platforms are quietly reshaping earnings power across medtech stocks....

13.01.26 - 01:45	Boston Scientific (BSX) Stock Drops Despite Market Gains: Important Facts to Note (Zacks)
	Boston Scientific (BSX) reached $95.72 at the closing of the latest trading day, reflecting a -1.97% change compared to its last close....

12.01.26 - 13:54	Boston Scientific To Acquire Valencia Technologies (AFX)
	WASHINGTON (dpa-AFX) - Boston Scientific Corp. (BSX), a medical devices manufacturer, Monday announced that it has agreed to acquire Valencia Technologies Corporation, a privately held medical tec......

12.01.26 - 13:03	Boston Scientific Announces Agreement to Acquire Valencia Technologies Corporation (PR Newswire)
	Acquisition to expand urology offerings for people living with overactive bladder MARLBOROUGH, Mass., Jan. 12, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced it has entered into a definitive agreement to acquire Valencia Technologies Corporation, a......

08.01.26 - 16:00	Is Boston Scientific Stock a Smart Pick for Your Portfolio Right Now? (Zacks)
	BSX is seeing solid international growth, MedSurg market-share gains and surging WATCHMAN sales, though macro and competition remain risks....

08.01.26 - 12:54	Boston Scientific Earnings Preview: What to Expect (Barchart)
	Um den gesamten Artikel unter newsbreak.com zu lesen, klicken Sie bitte auf die Überschrift...

07.01.26 - 17:30	Boston Scientific (BSX) Just Overtook the 50-Day Moving Average (Zacks)
	Is it a good or bad thing when a stock surpasses resistance at the 50-day simple moving average?...

07.01.26 - 16:00	If You Invested $1000 in Boston Scientific 10 Years Ago, This Is How Much You′d Have Now (Zacks)
	Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards....

07.01.26 - 01:45	Boston Scientific (BSX) Beats Stock Market Upswing: What Investors Need to Know (Zacks)
	The latest trading day saw Boston Scientific (BSX) settling at $97.79, representing a +2.42% change from its previous close....

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Soll man zur Beute werden, wieviel besser, / dem Löwen zuzufallen als dem Wolf. - William Shakespeare

Partner: >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram